4//SEC Filing
Doogan Declan 4
Accession 0001654954-24-015473
CIK 0000034956other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 7:58 PM ET
Size
9.3 KB
Accession
0001654954-24-015473
Insider Transaction Report
Form 4
Doogan Declan
Director
Transactions
- Award
Stock Option (right to buy)
2024-12-10+100,000→ 100,000 totalExercise: $5.94From: 2025-12-10Exp: 2034-12-10→ Common Stock (100,000 underlying)
Holdings
- 4
Stock Option (right to buy)
Exercise: $992.00From: 2023-06-09Exp: 2032-06-09→ Common Stock (4 underlying) - 2,274
Common Stock
- 4
Stock Option (right tob buy)
Exercise: $3200.00From: 2022-06-10Exp: 2031-06-10→ Common Stock (4 underlying)
Footnotes (3)
- [F1]The aggregate number of shares of common stock were previously reported as 3,637,871, but were adjusted to reflect the stock splits that occurred on January 4, 2023 and January 2, 2024.
- [F2]These options were previously reported as covering 6,250 shares at an exercise price of $2.00 per share, but were adjusted to reflect the stock splits that occurred on January 4, 2023 and January 2, 2024.
- [F3]These options were previously reported as covering 5,000 shares at an exercise price of $0.62 per share, but were adjusted to reflect the stock splits that occurred on January 4, 2023 and January 2, 2024.
Documents
Issuer
TENAX THERAPEUTICS, INC.
CIK 0000034956
Entity typeother
Related Parties
1- filerCIK 0001704234
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 7:58 PM ET
- Size
- 9.3 KB